Mannkind
MNKD • NASDAQ
Mannkind is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Michael E. Castagna, with a market cap of $833.7M.
Market Cap$833.7M
Employees414.0
CEOMichael E. Castagna
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 14, 2026 · In 2 weeksBefore Market Open · Q1 2026
Financials
Mannkind FAQ
Common questions about Mannkind
Mannkind is scheduled to report earnings for Q1 2026 on May 14, 2026 before market open. Analysts estimate revenue of $107.6M.
Mannkind has approximately 414 employees.